Gates Foundation And Previous Vaccine Efforts In India:

How Bill Gates-Funded NGO Killed Tribal Girls In India

HAF

In 2009, a Bill and Melinda Gates Foundation (BMGF) funded NGO carried out unauthorised clinical trials of a vaccine on some of the poorest, most vulnerable children in the world. It did so without providing information about the risks involved, without the informed consent of the children or their parents and without even declaring that it was conducting a clinical trial.

After vaccination, many of the participating children became ill and seven of them died. Such were the findings of a parliamentary committee charged with investigating this wretched affair. The committee accused the NGO of “child abuse” and produced a raft of evidence to back up its claim. This entire incident barely registered on the radar of Western media.

PATH (formerly the Program for Appropriate Technology in Health) is a Seattle based NGO, heavily funded by BMGF but which also receives significant grants from the US government. Between 1995 and the time of writing (May 2021), PATH had received more than $2.5bn from BMGF.

In 2009, PATH carried out a project to administer the Human Papillomavirus (HPV) vaccine.

The project’s aim was, in PATH’s own words, “to generate and disseminate evidence for informed public sector introduction of HPV vaccines”.

It was conducted in four countries: India, Uganda, Peru and Vietnam.

Another Gates-funded organization, Gavi, had originally been considered to run the project, but responsibility was ultimately delegated to PATH. The project was directly funded by BMGF.

Significantly, each of the countries selected for the project had a different ethnic population and each had a state-funded national immunisation program.

The use of different ethnic groups in the trial allowed for comparison of the effects of the vaccine across diverse population groups (ethnicity being a factor in the safety and efficacy of certain drugs).

It’s worth noting here the relationship between BMGF and one of the companies whose drugs were being tested. In 2002, BMGF had, controversially, bought $205m worth of stocks in the pharmaceutical sector, a purchase which included shares in Merck & Co. The move had raised eyebrows because of the obvious conflict of interest between the foundation’s role as a medical charity and its role as an owner of businesses in the same sector.

The Wall Street Journal reported, in August 2009, that the foundation had sold its shares in Merck between 31st March and 30th June of that year, which would have been around the same time that the field trials of the HPV vaccine were starting in India.

So for the entirety of this project (which was already in operation by October 2006), right up to its final field trials, BMGF had a dual role: as both a charity with a responsibility for care, and as a business owner with a responsibility for profit.

Such conflicts of interest have been a hallmark of BMGF since 2002. When Gates was making regular TV appearances last year to promote Covid-19 vaccination, giving especially ringing endorsements of the Pfizer-BioNTech effort, his objectivity was never brought into question. Yet his foundation is the part-owner of several vaccine manufacturers, including Pfizer, BioNTech and CureVac.

Some 14,000 girls were injected with Gardasil in Khammam district during 2009. The girls recruited for PATH’s project were between 10 and 14 years of age and all came from low-income, predominantly tribal backgrounds. Many of the girls did not reside with their families; instead they lived in ashram pathshalas (government-run hostels), which were situated close to the schools the children attended.

Professor Linsey McGoey, of the University of Essex, later stated she believed girls at ashram pathshalas had been targeted for the project as this was a way of “side-stepping the need to seek parental consent for the shots.”

Despite concerns expressed about the project in October 2009 by Sama, a Delhi-based NGO that advocates for women’s health, the matter remained absent from India’s news.

This project, then, couldn’t have been more off-the-map had it taken place on the moon, and it remained so for several months until, early in 2010, stories began to filter out from Khammam that something had gone terribly wrong: many of the girls who had been involved in the trials had subsequently fallen ill and four of them had died.

In March 2010, members of Sama visited Khammam to find out more about the emerging stories. They were told that up to 120 girls had experienced adverse reactions, including epileptic seizures, severe stomach ache, headaches and mood swings. The Sama representatives remained in Khammam to investigate the situation further.

The involvement of Sama finally brought the matter to the attention of the Indian media and, amid a barrage of negative publicity, the Indian Council of Medical Research (IMCR) suspended the PATH project. At this point the Indian Parliament’s Standing Committee on Health began an investigation into the affair.

On May 17th, Sama produced a damning report highlighting, among other things: that the trials had been promoted as a government immunisation programme and not a research project, that the girls had not been made aware that they could choose not to participate in the trials, and that parental consent had neither been asked for nor given in many cases.

More...